Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)

NCT05466890 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis
Ulcerative Colitis Acute
Ulcerative
Ulcerative Colitis Flare

Interventions

DRUG: PL8177 Placebo
DRUG: PL8177

Sponsor

Palatin Technologies, Inc